Cas:113216-88-9 [(R)-[(2S,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methyl] 4-chlorobenzoate manufacturer & supplier

Chemical Name:[(R)-[(2S,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methyl] 4-chlorobenzoate

CAS.NO:113216-88-9

Synonyms:Hydroquinine 4-chlorobenzoate;(1R)-((1S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methyl 4-chlorobenzoate;O-(4-chlorobenzoyl)-hydroquinine;Dihydroquinine 4-chlorobenzoate;10,11-dihydroquinine p-chlorobenzoate;MFCD00161486

Molecular Formula:C₂₇H₂₉ClN₂O₃

Molecular Weight:464.98400

HS Code:

Physical and Chemical Properties:

Melting point:128-130ºC(lit.)

Boiling point:598ºC at 760mmHg

Density:1.28g/cm3

Index of Refraction:1.639

PSA:51.66000

Exact Mass:464.18700

LogP:5.85320

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1544

Packing Group:III

Contact us for information like Hydroquinine 4-chlorobenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00161486 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,10,11-dihydroquinine p-chlorobenzoate Use and application,Hydroquinine 4-chlorobenzoate technical grade,usp/ep/jp grade.

Related News: It has also been possible to prepare enzymes that can function effectively in organic solvents, thereby dramatically increasing the number of reactions possible. 4-benzoyl-3-phenyl-5-phenylaminothiophene-2-carboxylic acid ethyl ester manufacturers The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. (24Ξ)-3β-benzoyloxy-24-methyl-9β,19-cyclo-31-nor-lanostane suppliers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. (S)-N-((3-(4-(4-(1,2,4-thiadiazol-5-yl)piperazin-1-yl)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide vendor & factory The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance.,Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA.